| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |